"If you're not at the table, you're on the menu," says former Goldman Sachs VP, Dr. David Eifrig.
This biotech currently has four drugs in mid to late-stage clinical trials. And any one that gets approved could send their share price skyrocketing. Institutional investors are taking notice...They more than doubled their stock purchases of the company in the final quarter of 2023...Do they know something you don't?
25X Predicted For THIS Crypto -- Starting on June 24th, this tiny 3-cent crypto just partnered with one of the biggest companies in the world... Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the No. 1 Crypto of 2024 here.
In December 2023, 22 countries pledged to 3X their nuclear capacity. Sending these uranium stocks into a frenzy. Here's 1 uranium miner that exploration records show is sitting on 2.4 million pounds of uranium.
The former Goldman Sachs VP -- who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio -- is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."
This biotech currently has four drugs in mid to late-stage clinical trials. And any one that gets approved could send their share price skyrocketing. Institutional investors are taking notice...They more than doubled their stock purchases of the company in the final quarter of 2023...Do they know something you don't?